(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...

Over the decades, scientists have revealed many strategies that keep normal cells from becoming cancerous. Understanding natural anti-tumor processes could help researchers develop better approaches ...

Merck & Co. and Eisai’s Lenvima has posted its share of positive data readouts over the years, but bladder cancer remains a tough nut to crack. In newly released trial results, Lenvima’s addition to ...

In May, surgeons at USC and UCLA collaborated to perform the world’s first-in-human bladder transplant. Currently, when a bladder fails or needs to be removed, doctors create a “neobladder” using a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The drug is approved for breast ...

June 27 (Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday its treatment for bladder pain syndrome failed to meet the main goal of a late-stage trial, and the company plans to stop developing ...